Patient access to Affordable Cancer Drugs

Please use this identifier to cite or link to this item: 192.168.6.56/handle/123456789/33067

Full metadata record

DC Field	Value	Language
dc.contributor.author	National Cancer Policy Forum	-
dc.date.accessioned	2019-01-01T10:07:50Z	-
dc.date.available	2019-01-01T10:07:50Z	-
dc.date.issued	2014	-
dc.identifier.isbn	978-0-309-31270-7	-
dc.identifier.uri	http://10.6.20.12:80/handle/123456789/33067	-
dc.description	This book discuss costs include health insurance deductibles, coinsurance, and copayments for covered services, as well as services that are not covered by insurance. Many cancer patients are especially vulnerable financially because their illness and/or treatment impedes their ability to work, with some patients losing employment altogether. Even with insurance, cancer patients often experience financial hardships, such as going into debt, depleting all assets to pay for cancer treatment, and personal bankruptcy. Although many elements contribute to the cost of cancer care, one important component is the cost of new cancer drugs, which has been escalating rapidly in recent years.	-
dc.language.iso	en	en_US
dc.publisher	Washington, DC	en_US
dc.subject	Affordable Cancer Drugs	en_US
dc.title	Patient access to Affordable Cancer Drugs	en_US
dc.type	Book	en_US
Appears in Collections:	Medical Labratory

Files in This Item:

File	Description	Size	Format
pdf.47		2.21 MB	Unknown	View/Open